Gene aberrations for precision medicine against lung adenocarcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Motonobu,Saito

第一单位： Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.;Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.

作者： Motonobu,Saito ^[1] ; Kouya,Shiraishi ^[2] ; Hideo,Kunitoh ^[3] ; Seiichi,Takenoshita ^[4] ; Jun,Yokota ^[5] ; Takashi,Kohno ^[2]

作者单位： Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.;Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan. ^[1] Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan. ^[2] Department of Medical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan. ^[3] Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan. ^[4] Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.;Cancer Genome Biology Group, Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain. ^[5]

关键词 Chromatin remodeling genes driver oncogene aberration gene fusion molecular targeting therapy smoking

主题词腺癌(Adenocarcinoma);人类(Humans);肺肿瘤(Lung Neoplasms);突变(Mutation);癌基因(Oncogenes)

DOI 10.1111/cas.12941

PMID 27027665

发布时间 2022-04-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交